New Year, new opportunities
In her latest blog our CEO, Gail Jackson reflects on entering a new year and what 2021 and beyond may bring for the charity.
Solving Kids' Cancer's Support for DIPG Community Petition
Solving Kids’ Cancer is proud to stand beside Fiona Govan and the entire DIPG community, following their incredible advocacy work calling for increased funding for research into the most difficult-to-treat childhood cancers.
Research update- December 2020
We are delighted to have announced the first International Neuroblastoma Research Initiative award to be funded under our AMRC-accredited research funding process, which will see a targeted drug introduced to frontline treatment for children with the hope
Landmark Transatlantic Trial
Grant awarded to Children’s Hospital of Philadelphia (CHOP) and Gustave Roussy in Paris to support Phase 3 clinical trial, representing the first-ever collaboration between these North American and European neuroblastoma consortia.
Celebrating success and acknowledging challenge
Our CEO, Gail, reflects on 'Pandemic Fatigue' and the importance of celebrating success in the face of challenge.
Research update - September 2020
This Autumn we are extremely busy with our ongoing International Neuroblastoma Research Initiatives.
First three months
Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.
Research update- July 2020
The impact of COVID-19 has been serious and will have long-lasting consequences for medical research in the UK, not least because so much of our medical research is funded by charities.
Supporting Decision Making - REDMAPP Study
The REDMAPP research study aims to develop a decision aid to support parents when their child has relapsed neuroblastoma by first gaining a greater understanding of how parents make a series of repeated treatment-related decisions.
